UBS’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$112K Buy
1,500
+700
+88% +$50.9K ﹤0.01% 5859
2014
Q2
$55K Buy
800
+500
+167% +$34K ﹤0.01% 6731
2014
Q1
$21K Buy
300
+200
+200% +$13.9K ﹤0.01% 8001
2013
Q4
$7K Buy
+100
New +$6.11K ﹤0.01% 9299
2013
Q3
Sell
-800
Closed -$38K 10367
2013
Q2
$38K Buy
+800
New +$36.5K ﹤0.01% 7076

Other funds holding CAH

UBS's CAH Position: Q3 2014 in Review

UBS increased its Cardinal Health (CAH) stake by 5.4% in Q3 2014, buying an estimated $1.41M and bringing the position to 374,358 shares worth $28M. The position accounts for 0.02% of the portfolio, ranked #753.

UBS first reported a position in CAH in Q2 2013 and has held it in 6 quarters since. The position peaked at $32.3M in Q3 2013. 643 funds tracked by Wall St. Rank hold CAH as of Q3 2014.

  • UBS held 374,358 shares of Cardinal Health worth $28M as of Q3 2014.
  • UBS bought 19,339 Cardinal Health shares in Q3 2014, an estimated $1.41M.
  • Cardinal Health made up 0.02% of UBS's portfolio in Q3 2014, its #753 holding.
  • UBS first reported a position in Cardinal Health in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cardinal Health position peaked at $32.3M in Q3 2013.
  • 643 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.